Recent Finacing
Recent Raise
Oricula Therapeutics develops a co-therapy that protects inner-ear hair cells from aminoglycoside-induced damage while preserving antibiotic bactericidal activity, advancing through zebrafish and rat preclinical studies from Washington University–derived technology.
Focus Areas
Funding round